Who is Defining the Standard of Care? Clinical Trial vs. Real World Patients with Lung Cancer


The rate of our progress in lung cancer and other settings in medicine reaches a bottleneck in the slow rate at which clinical trials are completed. Nevertheless, only about 3% of patients with cancer in the US participate in clinical trials, and the number is even a little lower for people with lung cancer.

Subscribe to comorbidity